As filed with the Securities and Exchange Commission on July 13, 2007
Registration No. 333-
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
AMGEN INC.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 95-3540776 | |
| (State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification Number) |
One Amgen Center Drive
Thousand Oaks, California 91320-1799
(Address of Principal Executive Offices including Zip Code)
RETIREMENT AND SAVINGS PLAN FOR AMGEN MANUFACTURING, LIMITED
(Full Title of the Plan)
| Copy to: | ||
| David J. Scott, Esq. | Charles Ruck | |
| Senior Vice President, General Counsel and | Regina Schlatter | |
| Secretary | Latham & Watkins LLP | |
| One Amgen Center Drive | 650 Town Center Drive, 20th Floor | |
| Thousand Oaks, California 91320-1799 | Costa Mesa, California 92626 | |
| (805) 447-1000 | (714) 540-1235 |
(Name, Address, Including Zip Code, and Telephone Number,
Including Area Code, of Agent for Service)
CALCULATION OF REGISTRATION FEE
| Title of Securities to be Registered |
Amount to be Registered(1) |
Proposed Maximum Offering Price Per Share(2) |
Proposed Maximum Aggregate Offering Price(2) |
Amount of Registration Fee | |||||||
| Common Stock, par value $0.0001 per share |
750,000 | $ | 54.59 | $ | 40,942,500.00 | $ | 1,256.93 | ||||
| (1) | 750,000 shares of common stock, par value $0.0001 per share (the “Common Stock”) of Amgen Inc., a Delaware corporation (the “Company”), are being registered hereunder. Such number represents shares that may be purchased in the open market pursuant to the Retirement and Savings Plan for Amgen Manufacturing, Limited (as the successor plan to the Retirement and Savings Plan for Amgen Manufacturing, Inc.) (the “Plan”). Pursuant to Rule 416(c) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers an indeterminate amount of interests to be offered or sold pursuant to the Plan. In addition, pursuant to Rule 416(a) under the Securities Act, this Registration Statement shall automatically cover any additional shares of Common Stock that become purchasable under the Plan by reason of any stock dividend, stock split or other similar transaction. |
| (2) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(h) and (c) under the Securities Act. The price per share and aggregate offering price for the shares of Common Stock are calculated on the basis of the average of the high and low trading prices of the Common Stock, as reported on the NASDAQ Global Select Market on July 10, 2007. |
Proposed issuances to commence as soon after the effective date of the Registration Statement as practicable.
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
The information called for in Part I of the Form S-8 is not being filed with or included in this Form S-8 (by incorporation by reference or otherwise) in accordance with the rules and regulations of the Securities and Exchange Commission (the “Commission”).
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Registration of Additional Securities
The Company has previously registered 160,000 shares of Common Stock, after giving effect to stock splits, that may be purchased under the Plan by a Registration Statement on Form S-8 filed with the Commission on May 4, 1992, Registration No. 33-47605, as amended (the “Prior Registration Statement”). Under this Registration Statement, the Company is registering an additional 750,000 shares of Common Stock that may be acquired under the Plan. The content of the Prior Registration Statement is incorporated by reference herein to the extent not modified or superseded thereby or by any subsequently filed document that is incorporated by reference herein or therein.
Experts
The financial statements and management’s report on the effectiveness of internal control over financial reporting incorporated in this Registration Statement by reference from the Company’s Annual Report on Form 10-K for the year ended December 31, 2006 have been audited by Ernst & Young LLP, an independent registered public accounting firm, as stated in their report, which is incorporated herein by reference, and have been so incorporated in reliance upon the report of such firm given upon their authority as experts in accounting and auditing.
| Item 8. | Exhibits. |
See the Index to Exhibits on page 4.
The Company previously received a determination letter from the Treasury Department of the Commonwealth of Puerto Rico (the “Treasury Department”), dated October 21, 2003, opining that the Plan meets the requirements of Section 1165(a) of the Puerto Rico Internal Revenue Code of 1994, as amended (the “Code”). On April 20, 2007, the Company submitted an application to the Treasury Department for a new determination letter with respect to the Plan, as amended since the date of the prior determination letter. The Company hereby undertakes that it has submitted the Plan and any amendments thereto to the Treasury Department and has made or will make all changes required by the Treasury Department in order to continue to maintain qualification of the Plan.
1
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant, Amgen Inc., a Delaware corporation, certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Thousand Oaks, State of California, on this 13th day of July 2007.
| AMGEN INC. | ||
| By: | /s/ Kevin W. Sharer | |
| Kevin W. Sharer | ||
| Chairman of the Board, Chief Executive Officer and President | ||
POWER OF ATTORNEY
KNOW ALL MEN AND WOMEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Kevin W. Sharer, Robert A. Bradway and David J. Scott, or any of them, his or her attorney-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendments (including, without limitation, post-effective amendments) and supplements to this Registration Statement, and any related registration statements, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his or her substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons on behalf of the registrant and in the capacities on the dates indicated:
| Signature |
Title |
Date | ||
| /s/ Kevin W. Sharer Kevin W. Sharer |
Chairman of the Board, Chief Executive Officer and President, and Director (Principal Executive Officer) |
July 13, 2007 | ||
| /s/ Robert A. Bradway Robert A. Bradway |
Executive Vice President and Chief Financial Officer (Principal Financial Officer) |
July 13, 2007 | ||
| /s/ Michael A. Kelly Michael A. Kelly |
Vice President, Finance and Chief Accounting Officer (Principal Accounting Officer) |
July 13, 2007 | ||
| /s/ David Baltimore David Baltimore |
Director | July 13, 2007 | ||
| /s/ Frank J. Biondi, Jr. Frank J. Biondi, Jr. |
Director | July 13, 2007 | ||
| /s/ Jerry D. Choate Jerry D. Choate |
Director | July 13, 2007 | ||
| /s/ Frederick W. Gluck Frederick W. Gluck |
Director | July 13, 2007 | ||
2
| /s/ Frank C. Herringer Frank C. Herringer |
Director | July 13, 2007 | ||
| /s/ Gilbert S. Omenn Gilbert S. Omenn |
Director | July 13, 2007 | ||
| /s/ Judith C. Pelham Judith C. Pelham |
Director | July 13, 2007 | ||
| /s/ J. Paul Reason J. Paul Reason |
Director | July 13, 2007 | ||
| /s/ Leonard D. Schaeffer Leonard D. Schaeffer |
Director | July 13, 2007 | ||
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the trustee (or other persons who administer the Retirement and Savings Plan for Amgen Manufacturing, Limited) has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Thousand Oaks State of California, on this 13th day of July 2007.
| RETIREMENT AND SAVINGS PLAN FOR AMGEN MANUFACTURING, LIMITED | ||||
| By: |
AMGEN MANUFACTURING, LIMITED | |||
| Plan Administrator | ||||
| By: |
/s/ Robert A. Bradway | |||
| Robert A. Bradway, Chief Financial Officer | ||||
3
INDEX TO EXHIBITS
| EXHIBIT |
DESCRIPTION | |
| 4.1 |
Restated Certificate of Incorporation (as restated December 6, 2005). (1) | |
| 4.2 |
Amended and Restated Bylaws of Amgen Inc. (as amended and restated February 14, 2007). (2) | |
| 4.3 |
Form of stock certificate for the common stock, par value $0.0001 of Amgen Inc. (3) | |
| 4.4 |
Registration Rights Agreement, dated as of November 18, 2004, among Amgen Inc. and Morgan Stanley & Co. Incorporated and Merrill Lynch, Pierce, Fenner & Smith Incorporated. (4) | |
| 4.5 |
Registration Rights Agreement, dated as of February 17, 2006, among Amgen Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. Incorporated, Citigroup Global Markets Inc., JPMorgan Securities Inc., Lehman Brothers Inc., Bear, Stearns & Co. Inc., Credit Suisse Securities (USA) LLC. (5) | |
| 5* |
Determination letter issued by the Treasury Department of the Commonwealth of Puerto Rico, dated October 21, 2003. | |
| 23* |
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm. | |
| 24* |
Power of Attorney (included on the signature page to this Registration Statement). | |
| * | Filed herewith. |
| (1) | Filed as an exhibit to the Form 10-K for the year ended December 31, 2005 on March 10, 2006 and incorporated herein by reference. |
| (2) | Filed as an exhibit to the Current Report on Form 8-K on February 20, 2007 and incorporated herein by reference. |
| (3) | Filed as an exhibit to the Form 10-Q for the quarter ended March 31, 1997 on May 13, 1997 and incorporated herein by reference. |
| (4) | Filed as an exhibit to the Company’s Form 8-K on November 19, 2004 and incorporated herein by reference. |
| (5) | Filed as an exhibit to the Company’s Form 8-K on February 21, 2006 and incorporated herein by reference. |
4